Compare Okta, Inc. (OKTA) vs Tempus AI (TEM) Price & Performance

OKTA trades at $141.63, down 5.17% in the last session amid broader market volatility. The stock shows strong fundamental improvement with revenue growing to $2.61B in 2025 and achieving positive net income of $28M after years of losses. Technical indicators suggest a bullish trend with strong moving average signals, while oscillators remain neutral. Recent analyst coverage remains overwhelmingly positive with 37 buy ratings versus 2 sell ratings.

The outlook remains constructive given OKTA's position in the growing cybersecurity sector and improving profitability. Key risks include high valuation multiples (P/E of 107.54) and competitive pressures. The consensus price target of $127.96 suggests potential downside from current levels, though the high target of $175.00 indicates significant upside potential if execution continues.

Tempus AI (TEM) trades at $48.41, down 7.74% amid market reaction to its $1.5 billion acquisition of Personalis. The stock shows bearish technical signals with negative moving averages and oversold RSI levels. Fundamentally, the company maintains strong revenue growth ($1.27B in 2025) but faces significant losses (-$245M net income) and negative margins. Recent news highlights strategic expansion in cancer diagnostics through AI-driven platforms.

Despite analyst optimism (61.5% buy ratings, $68.50 target), TEM faces execution risks from the major acquisition and persistent profitability challenges. The stock's current discount to target offers potential upside if integration succeeds, but high cash burn and competitive pressures require careful monitoring for investors considering entry at these levels.